About xmahub
What this is
xmahub is an evidence-based eczema protocol designed to target root causes, not just symptoms. The protocol works through a structured 45-day system that addresses barrier repair, trigger identification, and sustained clearance. It was built for people who want a methodical approach to managing atopic dermatitis rather than cycling through topical treatments indefinitely.
How the protocol was built
The protocol was developed through systematic research into peer-reviewed dermatology literature, clinical guidelines, and barrier science. Every recommendation traces back to published evidence. Where the research was ambiguous or conflicting, the protocol defaults to the most conservative, well-supported position. The goal was to produce something clinically grounded, not speculative.
Why we built this
This protocol exists because the standard approach to eczema care is not working. The pattern is consistent: dermatologists have 10 minutes per appointment, repeat prescriptions for topical steroids, and no structured plan for identifying what is actually driving the flares. The information to build that plan exists in the research literature, scattered across hundreds of papers. Nobody had assembled it into something a patient could follow.
We built xmahub to fix that. The approach is structured and repeatable: a defined protocol, a clear sequence of interventions, and a tracking methodology that surfaces what is actually causing your flares. That rigour is what makes xmahub different from generic skincare advice. The structure is designed to give you answers, not just management strategies.
What xmahub is not
xmahub does not provide medical advice and is not a replacement for a qualified dermatologist. The protocol does not claim to cure eczema. It is an educational resource and structured framework based on published research. If you have severe or unresponsive eczema, consult a dermatologist. The protocol is designed to complement professional care, not replace it.
Sources and methodology
The protocol draws on peer-reviewed research from dermatology and immunology journals, clinical practice guidelines from bodies such as the British Association of Dermatologists and the American Academy of Dermatology, and current barrier science literature. Recommendations are graded by the strength of supporting evidence, and the protocol is reviewed and updated as new research is published.
Contact
For questions, feedback, or partnership enquiries, reach the team at hello@xmahub.com.